SpeechVive’s mission is to improve the quality of communication for people with Parkinson’s disease by empowering care partners and clinicians with technologies and support to restore one’s ability to communicate.
When Dr. Jessica Huber started researching the most efficient and effective way to increase speech volume for people with Parkinson’s, she discovered that using an automatic reflex of speaking in sound was more effective than traditional approaches. She searched for a device that would do just that — put a little “bubble of noise” in her patients’ ears. She discovered, nothing existed.
A conversation transpired between Jessica and biomedical engineers at Purdue University to discuss just what it would entail to give her patients the device she knew they needed.
Work began. Years passed, prototypes were developed, and clinical trials were completed. The technology worked. Patients could wear a device in a single ear and be automatically triggered to speak louder without any additional cuing or therapy.
Jessica took her amazing results to the biotech incubator on Purdue’s campus (The Alfred Mann Institute, AMIPurdue) where she met Managing Director, Steve Mogensen. AMIPurdue worked with Jessica on refining and developing the device. More prototypes and more testing continued to strengthen the product and the research behind it.
In 2013, Steve licensed the technology from Purdue and co-founded SpeechVive, Inc. with Jessica.
Steve and Jessica have built a team with years of experience in healthcare and Parkinson’s disease and are committed to creating life-changing moments for all our customers.